Trial Profile
the influence of a DPP-4 inhibitor, vildaglitpin, on hunger and the migrating motor complex in healthy volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Mar 2021 Status changed from recruiting to completed.
- 22 Aug 2014 New trial record